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SUMMARY
Aims: Treatments that increase acetylcholine release from brain slices decrease the
synthesis of phosphatidylcholine by, and its levels in, the slices. We examined whether
adding cytidine or uridine to the slice medium, which increases the utilization of choline to
form phospholipids, also decreases acetylcholine levels and release.
Methods: We incubated rat brain slices with or without cytidine or uridine (both 25–
400 µM), and with or without choline (20–40 µM), and measured the spontaneous and
potassium-evoked release of acetylcholine.
Results: Striatal slices stimulated for 2 h released 2650 ± 365 pmol of acetylcholine per
mg protein when incubated without choline, or 4600 ± 450 pmol/mg protein acetylcholine
when incubated with choline (20 µM). Adding cytidine or uridine (both 25–400 µM) to the
media failed to affect acetylcholine release whether or not choline was also added, even
though the pyrimidines (400 µM) did enhance choline`s utilization to form CDP-choline
by 89 or 61%, respectively. The pyrimidines also had no effect on acetylcholine release
from hippocampal and cortical slices. Cytidine or uridine also failed to affect acetylcholine
levels in striatal slices, nor choline transport into striatal synaptosomes.
Conclusion: These data show that cytidine and uridine can stimulate brain phosphatide
synthesis without diminishing acetylcholine synthesis or release.
KEY WORDS: cytidine; uridine; choline; phospholipid synthesis; acetylcholine release;
CDP-choline.
INTRODUCTION
The conversion of free choline to membrane phosphatidylcholine (PC) involves
its phosphorylation to phosphocholine; the reaction of phosphocholine with cyti-
dine triphosphate (CTP) to yield 5′-cytidine diphosphocholine (CDP-choline); and
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the transfer of that compound’s phosphocholine moiety to the free hydroxyl group
of diacylglycerol (DAG) (Kennedy and Weiss, 1956). The rates of all three reac-
tions can be influenced by substrate availability, i.e., choline administration ele-
vates brain phosphocholine (Millington and Wurtman, 1982); CTP levels limit the
formation of endogenous CDP-choline (Choy et al., 1980); and DAG levels, in-
creased when PC12 cells are differentiated by treatment with nerve growth factor
(NGF), control the rate at which these cells convert CDP-choline to PC (Araki
and Wurtman, 1997). The rate-limiting step in PC synthesis usually is the forma-
tion of CDP-choline from CTP and phosphocholine (Araki and Wurtman, 1997,
1998). Brain CTP levels are lower than those needed to saturate the enzyme (CTP:
phosphocholine cytidylyltransferase) that catalyses this reaction, thus giving cy-
tidine, which increases brain CTP, accelerates PC synthesis in both PC12 cells
(Lopez-Coviella and Wurtman, 1992) and rat brain slices (Savci and Wurtman,
1995). Similarly, incubation of PC12 cells with uridine, which is converted to
UTP and CTP (Wurtman et al., 2000; Richardson et al., 2003), also enhances
the formation of CDP-choline (Richardson et al., 2003), the immediate precursor
of PC.
Cholinergic neurons are unique in that they both acetylate and phosphory-
late choline, to form acetylcholine and phosphocholine (and, ultimately, phos-
phatidylcholine); the acetylation pathway is favored over phosphorylation when the
neurons are depolarized (Ando et al., 1987; Farber et al., 1996). Studies on stri-
atal slices have shown that addition of choline to the perfusion medium both in-
creases acetylcholine synthesis and release (Maire and Wurtman, 1985; Ulus et al.,
1989; Wecker et al., 1989) and enhances membrane phospholipid synthesis (Ulus
et al., 1989; Savci and Wurtman, 1995). However if cytidine was also added, phos-
phatidylcholine synthesis was increased (Savci and Wurtman, 1995), but the tis-
sue acetylcholine content reportedly declined (Savci and Wurtman, 1995). These
observations suggested that, in cholinergic neurons, increasing the conversion of
choline to membrane phospholipids might limit its availability for acetylcholine
synthesis.
Hence, the present study was designed to determine whether cytidine generally
suppresses the choline-induced stimulation of acetylcholine synthesis in, and release
from cholinergic neurons, i.e., in rat brain slices. Because uridine is the primary
circulating pyrimidine in humans (Wurtman et al., 2000), and is readily converted
in brain to UTP and then CTP (Cansev et al., 2005), we also tested the effects of
uridine on acetylcholine synthesis and release.
MATERIALS AND METHODS
Preparation and Perfusion of Slices
Male Sprague-Dawley rats (250–300 g) were anesthetized by intraperitoneal
injection of ketamine (60 mg/kg) and sacrificed by decapitation, and their brains
were rapidly removed. Striatal, hippocampal and cortical tissues were dissected
and 0.3 mm thick slices were prepared using a McIlwain tissue chopper (Brinkman
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Instruments, Westbury, NY). Tissue slices from two rats were combined and washed
with ice-cold medium to remove most of the membrane debris. Four to six striatal
slices were then transferred into each of eight superfusion chambers (volume, 1 mL).
When cortical or hippocampal slices were used, six to eight were placed in the acetyl-
choline superfusion chamber. The chambers were kept at 37◦C in a water bath,
and slices were equilibrated for 60 min with a physiological solution (millimolar:
NaCl, 120; KCl, 3.4; CaCl2, 1.3; MgSO4, 1.2; NaH2PO4, 1.2; NaHCO3, 25; glucose,
10 and eserine salicylate, 0.02) at a constant flow rate of 0.6 mL/min, by means of a
Rainin Rabbit eight-channel peristaltic pump (Rainin Instrument Co. Inc., Woburn,
MA). This solution was bubbled continuously with a mixture of 95% O2 and 5%
CO2.
After the 60-min equilibration period, slices were perfused for 120 min with a
choline-free or choline-containing (20–40 µM) high-potassium (52 mM) solution in
the presence or absence of cytidine (25, 100, 200 or 400 µM) or uridine (25, 100, 200
or 400 µM). During this stimulation period, perfusates representing 20-min frac-
tions or the entire 120-min period were collected in beakers on ice, and later as-
sayed for acetylcholine. At the end of the stimulation period, slices were removed
from the perfusion chamber and their choline and acetylcholine contents were
determined.
Extraction of Acetylcholine from Perfusates
Acetylcholine was extracted from the perfusates using a silica column pro-
cedure (Gilberstat and Russell, 1984) as described previously (Ulus et al., 1989).
Briefly, 2 mL of the perfusates were applied to a silica column (5 mm × 8 mm bed of
Bio-Sil A, 200–400 mesh, Bio-Rad Laboratories, CA). The column was then washed
successively with 1 mL of 0.001N HCl, 0.8 mL of 0.075N HCl and 1 mL of 0.003N
HCl in 10% (v/v) 2-butanone. The latter fraction (0.003N HCl in 10% 2-butanone)
was collected in glass tubes (13 mm × 75 mm) and dried under vacuum. To remove
any remaining choline the dried samples were then resuspended in 0.1 mL of Tris–
HCl buffer (50 mM; pH 8.00) containing MgCl2 (100 mM) and 2 U of choline ox-
idase (Sigma Chemical Co.) and incubated at 37◦C in water bath for 60 min. The
reaction was terminated by adding 1.9 mL of ice-cold distilled water, and then the
column procedure was repeated once again. The recovery of acetylcholine in the
final HCL-in-butanone fraction was about 60%, and that of choline less than 1%.
These final fractions were dried under vacuum and stored at –20◦C until assay for
acetylcholine. Acetylcholine standards (0–800 pmol) were prepared in 2 mL of the
same choline-containing medium as that used for superfusing the slices, and pro-
cessed in parallel with the samples.
Extraction of Acetylcholine from the Tissues
Slices were removed from the chamber and washed twice with ice-cold phys-
iological solution and then homogenized in 1 mL of cold water containing 0.02 M
eserine salicylate. Aliquots (0.2 mL) of the homogenates were mixed with 1 mL of
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ice-cold methanol; the mixtures were then vortexed and allowed to stand for about
2 h in a cold room after which they were centrifuged (1500 × g for 10 min). Super-
natant fluids were transferred to glass tubes and dried under vacuum. Acetylcholine
standards (0–800 pmol) were prepared in 0.2 mL of water and processed in parallel
with the samples.
Determination of Acetylcholine
Acetylcholine contents of dried samples obtained from perfusates or tissues
were determined by the radioenzymatic method (Gilberstat and Russell, 1984) de-
scribed previously (Ulus et al., 1989). In brief, any remaining choline in the samples
was first converted to unlabelled phosphocholine; the acetylcholine was then hy-
drolyzed by acetylcholinesterase; and the choline resulting from this hydrolysis was
phosphorylated by choline kinase (Sigma–Aldrich Corp., MO, USA) in the pres-
ence of [32P-γ] ATP (Amersham Biosciences Corp., NJ, USA). Labeled phospho-
choline was then separated from excess ATP by column chromatography, and quan-
titated using a liquid scintillation spectrometer (LS 6500, Beckman Coulter Inc.,
Fullerton, CA).
Determination of CDP-Choline in Striatal Slices
Slices were removed from the chamber, washed twice with ice-cold physiolog-
ical solution, and then homogenized in 1 mL of cold water. Aliquots (0.5 mL) of
the homogenates were mixed with 2 mL of ice-cold methanol; the mixtures were
vortexed and allowed to stand for about 2 h in a cold room and then centrifuged
(1500 × g for 10 min). Supernatant fluids were transferred to glass tubes and dried
under vacuum. The dried samples were reconstituted in 100 µL water and then
analyzed for CDP-choline by HPLC on an anion-exchange column (Alltech Hy-
persil APS-2, 5 µm, 250 mm × 4.6 mm) using a modification of the method of Sim-
monds et al. (1991), as described by Richardson et al. (2003). CDP-choline standards
(0–200 pmol) were prepared in 0.5 mL cold water and processed in parallel with the
samples.
Measurement of Choline Uptake in Striatal Synaptosomes
Male Sprague-Dawley rats (250–300 g) were anesthetized by intraperi-
toneal injection of ketamine (60 mg/kg) and sacrificed by decapitation; their
brains were then removed rapidly. Striatal tissues were dissected and homog-
enized in 10 volumes of cold sucrose (0.32 M). The homogenates were then
centrifuged at 1000 × g for 10 min; pellet was discarded and supernatant fluid
was centrifuged again at 10,000 × g for 10 min. The crude synaptosomal pel-
lets were resuspended in 50 volumes of sucrose (0.32 M) and used to ex-
amine high-affinity choline uptake. Aliquots (50 µL) of the synaptosomal sus-
pension were transferred to eppendorf tubes (1.5 mL) containing 950 µL of
ice-cold physiological medium (millimolar: NaCl, 120; KCl, 3.4; CaCl2, 1.3; MgSO4,
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1.2; NaH2PO4, 1.2; NaHCO3, 25; and glucose, 10). This medium also con-
tained 3.5 µM of (3H-methyl)-choline (about 30,000 dpm). Solutions were equi-
librated with a mixture of 95% O2 and 5% CO2 and drugs to be tested were
added to the mixture prior to incubation. Tubes were then transferred to a
Dubnoff shaker and incubated for 2.5, 5, 10 or 20 min at 37◦C, under 95% O2 and
5% CO2. Reactions were stopped by transferring tubes to an ice bath; tubes were
then centrifuged at 10,000 × g for 10 min at 4◦C. Pellets were washed in 1 mL of ice-
cold physiological medium twice, and their radioactivity was extracted by homog-
enization in 0.5 mL of distilled water using an ultrasonic homogenizer (Sonicator
Model W-225R, Heat Systems-Ultrasonics Inc., Plainview, NY). The homogenates
were then transferred to a small scintillation vial. Following addition of 4 mL of
Optifluor® and vigorous shaking, radioactivity was measured using a liquid scintil-
lation spectrometer (LS-6500, Beckman Coulter, Fullerton, CA). Blank values were
obtained by incubating the mixture at 4◦C or by incubating the mixture in the pres-
ence 5 µM hemicholinium-3.
Measurement of the Effect of Cytidine or Uridine on
[3H-Methyl]-Choline Incorporation Into Membrane
Phospholipids
Striatal slices were prepared and perfused as described previously, with omis-
sion of eserine salicylate. After the equilibration period, the slices were transferred
to incubation tubes and were incubated for 120 min in 1 mL of Krebs buffer con-
taining 3.2 µCi of [3H-methyl]-choline (final concentration of choline was 40 µM)
in the presence or absence of cytidine (400 µM) or uridine (400 µM) for 120 min.
At the end of the incubation period, slices were rinsed with 10 mL of ice-cold
Krebs buffer three times, and homogenized in 1 mL of ice-cold water. Aliquots
(4 × 20 mL) of the homogenate were taken for protein assay. The remaining ho-
mogenates were mixed and vortexed sequentially with 1 mL of methanol and 2 mL
of chloroform. The organic (lower) and aqueous (upper) phases of the mixtures
were separated by centrifugation (10 min at 4◦C; 2000 rpm). Aliquots (0.5 mL) of
the organic phase (containing phospholipids) were used for further separation of
the individual phospholipid classes followed by determination of their [3H-methyl]-
choline contents by liquid scintillation counter (LS-6500, Beckman Coulter,
Fullerton, CA). Briefly, aliquots (0.5 mL) of the lower phase were dried under
vacuum, and choline-containing individual phospholipid classes (phosphatidyl-
choline, lysophosphatidylcholine and sphingomyelin) were purified using thin
layer chromatography on silica gel G, with chloroform/ethanol/triethylamine/water
(30:34:30:8, v/v) as the mobile phase (Touchstone et al., 1980; Ulus et al., 1989).
Bands representing the choline-containing phospholipid classes were scraped
off the plates and extracted with 1 mL of methanol. Aliquots (0.8 mL) of the
methanol extracts were transferred to a large scintillation vial and, following
addition of 15 mL of Optifluor®, quantified using a liquid scintillation counter
(LS-6500, Beckman Coulter, Fullerton, CA), and an automated quench correction
program.
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Statistical Analysis
Data are expressed as means ± SEM. Statistical analyses were performed by
one- or two-way ANOVA followed by Tukey test. Values of p less than 0.05 were
considered to be significant.
RESULTS
Effects of Cytidine and Uridine on Acetylcholine Release
from Brain Slices
In the first set of experiments, acetylcholine release from brain slices at rest and
during stimulation were examined in the presence or absence of exogenous choline
added to perfusion medium. The rates of acetylcholine release during superfusion
at rest, without or with exogenously added choline (20 µM), were 86 ± 10 versus
138 ± 18 pmol/20 min/mg protein (n = 6; p < 0.05) for striatal slices; 45 ± 8 versus
78 ± 12 pmol/20 min/mg protein (n = 6; p < 0.05) for hippocampal slices and 28 ± 5
versus 48 ± 6 pmol/20 min/mg protein (n = 6; p < 0.05) for cortical slices, respec-
tively (Fig. 1). When slices were stimulated with 52 mM K+, acetylcholine release
increased several folds during the first 20 min stimulation period and then decreased
gradually, approaching basal rates during the next five 20 min stimulation periods
(Fig. 1A, C and E). In the presence of exogenously added choline (20 µM), acetyl-
choline release from the slices was further increased, and was better maintained
during the 2 h stimulation period than the release observed in the absence of exoge-
nous choline (Fig. 1). For striatal, hippocampal or cortical slices (Fig. 1B, D and F),
the total amounts of acetylcholine released into the medium during the entire 2 h
stimulation period were increased by about 111, 121 or 67% after addition of 20 µM
of choline, respectively.
The effects of cytidine, uridine, choline, and their combinations on acetyl-
choline release from rat striatal, hippocampal and cortical slices were tested in a
separate set of experiments. As seen in Fig. 2, neither cytidine (25 µM) nor uri-
dine (25 µM) altered the stimulated release of acetylcholine from striatal, hip-
pocampal or cortical slices, regardless of whether choline also was added. Similarly,
though, acetylcholine release was augmented when choline (20 µM) was added to
the medium (Fig. 2), this elevation also was unaffected by including cytidine or uri-
dine in the medium (Fig. 2).
Cytidine (25–400 µM) or uridine (25–400 µM) also failed to alter basal or stim-
ulated acetylcholine release in the presence of a higher concentration (40 µM) of
choline (Table I).
Effects of Cytidine and Uridine on Tissue Acetylcholine
Contents in Striatal Slices
Tissue acetylcholine contents in striatal slices perfused at rest for 2 h in the
absence or presence of exogenous choline were similar (Table II). When striatal
slices were stimulated with 52 mM K+ for 2 h, tissue levels of acetylcholine were
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Fig. 1. Acetylcholine release from striatal, hippocampal and cortical slices during a 120-min stimulation
period. Striatal (A and B), hippocampal (C and D) and cortical slices (E and F) were perfused with an
eserine-containing normal Krebs medium at rest for 40 min. After the 40-min equilibration period, slices
were perfused at rest for 20 min and then stimulated for 2 h with high K+ (52 mM) in the presence
[Ch( + )] or absence [Ch( − )] of choline (20 µM). Perfusates were collected for seven 20-min periods,
starting at rest (1) and then during the 2-h stimulation (2–7) and assayed for acetylcholine. Values were
normalized for the protein contents of each set of slices. Data are expressed as picomoles per milligram
protein per 20 min (A, C and E) or per 2 h (B, D and F) and shown as means ± SEM; N = 6. ∗p < 0.01;
∗∗p < 0.001 higher than the respective values obtained with that in the absence of choline [Ch( − )].
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Fig. 2. Effects of cytidine or uridine on stimulated acetylcholine release from
striatal, hippocampal and cortical slices in the presence or absence of choline in
the medium. Brain slices were perfused with an eserine-containing normal Krebs
medium. After a 60-min equilibration period, slices were perfused with an eserine-
containing high K+ (52 mM) Krebs medium for 2 h in the presence [Ch( + )] or ab-
sence [Ch( − )] of choline (20 µM). During this latter period, cytidine (25 µM) or
uridine (25 µM) was added into the medium. Perfusates were collected during the en-
tire 2-h period and assayed for acetylcholine. Values were normalized for the protein
contents of each set of slices. Data are expressed as picomoles per milligram protein
per 2 h, and shown as means ± SEM; N = 8. ∗p < 0.001 higher than the respective
values obtained with that in the absence of choline [Ch( − )].
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Table I. Effects of Cytidine or Uridine on Acetylcholine Release from Striatal Slices at Rest and
During Stimulation in the Presence of 40 µM Exogenously Added Choline in the Medium
Acetylcholine release (pmol/2 h/mg protein)
Medium N Rest Stimulation
Cytidine (0) 6 2200 ± 400 10150 ± 860∗
Cytidine (25 µM) 6 2225 ± 525 10600 ± 450∗
Cytidine (100 µM) 6 2200 ± 400 10600 ± 440∗
Cytidine (200 µM) 6 2000 ± 400 8500 ± 350∗
Cytidine (400 µM) 6 2200 ± 350 8900 ± 670∗
Uridine (0) 6 2650 ± 380 8600 ± 450∗
Uridine (25 µM) 6 2500 ± 475 8850 ± 750∗
Uridine (100 µM) 6 2400 ± 400 10500 ± 950∗
Uridine (200 µM) 6 2600 ± 300 9500 ± 625∗
Uridine (400 µM) 6 2200 ± 400 10000 ± 875∗
Note. Striatal slices were perfused with an eserine-containing normal Krebs medium. After a 60-min
equilibration period, slices were perfused for 2 h at rest or during stimulation (with 52 mM of K+) in
the absence (0) or presence of cytidine (25–400 µM) or uridine (25–400 µM) with exogenously added
choline (40 µM) in the medium. Perfusates were collected during the entire 2-h period and assayed for
acetylcholine. Values were normalized for the protein contents of each set of slices. Data are expressed
as picomoles per milligram protein per 2 h, and shown as means ± SEM; N = 6.
∗p < 0.001 (when compared with the respective values at rest).
Table II. Effects of Cytidine or Uridine on Acetylcholine Content in Striatal Slices at Rest and During
Stimulation in the Absence or Presence of 40 µM Exogenously Added Choline in the Medium
Condition/treatment N Rest Stimulation
Absence of choline
Cytidine (0) 4 1700 ± 100 430 ± 25∗
Cytidine (25 µM) 4 1690 ± 130 520 ± 65∗
Cytidine (100 µM) 4 1725 ± 100 470 ± 25∗
Cytidine (200 µM) 4 1850 ± 140 550 ± 20∗
Cytidine (400 µM) 4 1750 ± 100 460 ± 20∗
Uridine (0) 4 1780 ± 110 500 ± 75∗
Uridine (25 µM) 4 1980 ± 100 550 ± 80∗
Uridine (100 µM) 4 1830 ± 100 510 ± 55∗
Uridine (200 µM) 4 1780 ± 120 550 ± 50∗
Uridine (400 µM) 4 1690 ± 140 590 ± 40∗
Presence of 40 µM choline
Cytidine (0) 6 1800 ± 125 790 ± 65∗∗
Cytidine (25 µM) 6 1825 ± 150 830 ± 80
Cytidine (100 µM) 6 1875 ± 230 810 ± 50∗∗
Cytidine (200 µM) 6 1880 ± 180 850 ± 95∗∗
Cytidine (400 µM) 6 1900 ± 150 795 ± 90∗∗
Uridine (0) 6 1910 ± 120 830 ± 70∗∗
Uridine (25 µM) 6 1890 ± 100 790 ± 80∗∗
Uridine (100 µM) 6 2090 ± 220 765 ± 75∗∗
Uridine (200 µM) 6 1960 ± 110 845 ± 45∗∗
Uridine (400 µM) 6 2010 ± 220 815 ± 65∗∗
Note. Striatal slices were perfused with an eserine-containing normal Krebs medium. After a 60-min
equilibration period, slices were perfused with an eserine-containing high K+ (52 mM) Krebs medium
for 2 h in the absence or presence of choline (40 µM). During this latter period, cytidine (25–400 µM)
or uridine (25–400 µM) was added into the medium. At the end of 2-h period, slices were removed from
the chambers and assayed for protein and acetylcholine. Acetylcholine values were normalized for the
protein contents of each set of slices. Data are expressed as picomoles per milligram protein, and shown
as means ± SEM; N = 4–6.
∗p < 0.001 (when compared with the respective values at rest); ∗∗p < 0.01 (when compared with the
respective values observed in the absence of choline).
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reduced by about 75% in the absence, or by 55% in the presence of 40 µM choline
(Table II). Neither cytidine (25–400 µM) nor uridine (25–400 µM) affected stri-
atal acetylcholine levels in slices at rest or after stimulation, whether or not choline
(40 µM) was also added to the medium.
Effects of Cytidine and Uridine on Choline Uptake
in Striatal Synaptosomes
Figure 3 illustrates effects dose- and time course studies on effects of cytidine
or uridine on choline uptake into striatal synaptosomes. Cytidine or uridine, at 25–
800 µM concentrations, failed to affect choline uptake into striatal synaptosomes
(Fig. 3).
Effects of Cytidine and Uridine on [3H-Methyl]-Choline
Incorporation into Membrane Phospholipids
Cytidine significantly [F(4, 35) = 3.92; p < 0.01] enhanced [3H-methyl]-choline
incorporation into membrane phospholipids (Fig. 4). Uridine also tended to in-
crease [3H-methyl]-choline incorporation into membrane phospholipids; however
this effect failed to attain statistical significance at any of the concentrations tested
(100–800 µM).
Effects of Cytidine and Uridine on Tissue CDP-Choline Levels
Measurements of tissue CDP-choline accumulation have been shown to pro-
vide a more sensitive indication of the rate of PC synthesis than measuring changes
in PC itself, since CDP-choline’s pool size is orders of magnitude less than, and its
overall turnover rate considerably faster than, that of PC. Hence, we examined the
effect of cytidine or uridine supplementation on CDP-choline levels in striatal slices
perfused with cytidine (400 µM) or uridine (400 µM) for 2 h in the presence of
choline (40 µM). Cytidine and uridine both increased tissue CDP-choline levels, by
about 88% (p < 0.01) and 62% (p < 0.05), respectively (Table III).
DISCUSSION
These data show that although cytidine and uridine increase the rates at which
rat brain slices incorporate choline into CDP-choline and then phosphatidylcholine,
they do not alter basal or stimulated acetylcholine release from the slices, nor the
effects of choline on this release (Fig. 2). Even though both cytidine and uridine
(400 µM) increased CDP-choline levels in the slices (Table III), they had no effect
on acetylcholine release from the brain slices (Fig. 2) nor on striatal acetylcholine
levels (Table II). Cytidine or uridine also failed to modify tissue acetylcholine lev-
els (Table II), or choline transport into cholinergic nerve endings by the high-
affinity choline uptake system. Hence, using the pyrimidines to promote membrane
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Fig. 3. Effects of cytidine or uridine on choline transport into the striatal synap-
tosomes by high affininity choline transporter. Upper figure: striatal synaptosomes
were incubated with Krebs medium containing 3.5 µM (methyl-3H)-choline for
10 min at 37◦C in the absence (0) or presence of cytidine (25–800 µM) or uri-
dine (25–800 µM). Lower figure: striatal synaptosomes were incubated with Krebs
medium containing 3.5 µM (methyl-3H)-choline for 2.5, 5, 10, 15 or 20 min
at 37◦C in the absence (control) or presence of cytidine (800 µM) or uridine
(800 µM). At the end of the incubation period synaptosomes were collected
by centrifugation and their radioactivity was extracted and measured. Data for
choline uptake are expressed as picomole per milligram tissue per 10 min (up-
per figure) or picomole per milligram tissue (lower figure) and shown as means
± SEM; N = 6.
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Fig. 4. Effects of cytidine or uridine on [3H]-choline incorporation into mem-
brane phospholipids in striatal slices. Striatal slices were incubated for 2 h in the
presence of cytidine (100–800 µM) or uridine (100–800 µM) plus [3H]-choline.
Slices were washed and homogenized. Aliquots of homogenates were extracted in
methanol/chloroform. Aliquots (0.5 mL) of the organic phase were used for deter-
mination of [3H-methyl]-choline in phospholipids. ∗p < 0.05 different from the value
observed in the absence of cytidine (0 µM).
phosphatide synthesis will probably not diminish acetylcholine-mediated neuro-
transmission.
In contrast, when the use of choline in brain slices to form acetylcholine was
increased by repeated depolarization, both PC synthesis (Farber et al., 1996) and
its levels declined significantly (Ulus et al., 1989). If the striatal slices were stimu-
lated electrically for four to eight 20min periods, with 20min resting intervals, the
greatly increased release of acetylcholine into the perfusion medium was accom-
panied by a decrease in tissue PC content by 13–25% (“autocannibalism”; Ulus
et al., 1989). Addition of choline (10–40 µM) to the perfusion medium protected
Table III. Effects of Cytidine or Uridine on Tissue CDP-Choline Levels
Treatment N CDP-choline (pmol/mg protein)
Control 8 20.2 ± 2.2
Cytidine (400 µM) 8 38.2 ± 4.1∗∗
Uridine (400 µM) 8 32.6 ± 3.7∗
Note. Striatal slices were incubated for 2 h in Krebs buffer containing cytidine (400 µM) or uridine
(400 µM) in the presence of exogenously added choline (40 µM). Slices were washed and homogenized.
Aliquots of the homogenates were extracted in methanol/chloroform. Aliquots of the aqueous phases
were used for determination of CDP-choline.
∗p < 0.01; ∗∗p < 0.01 (different from control).
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against the stimulus-induced decrease in membrane phosphatide levels, and in-
creased the release of acetylcholine (Ulus et al., 1989). The present results are
in accord with previous reports (Maire and Wurtman, 1985; Wecker et al., 1989;
Ulus et al., 1989), and show that brain slices do continue to synthesize and re-
lease the neurotransmitter acetylcholine even when exogenous choline has not been
added to the perfusion medium, and that when they are depolarized (e.g., with high
K+; 52 mM) they release larger amounts of acetylcholine. The addition of choline
(20 µM) to the perfusion medium in this circumstance further increased acetyl-
choline release (Fig. 1). But the addition of cytidine or uridine to the medium—
which promoted CDP-choline (Table III) and thus PC synthesis—failed to diminish
acetylcholine release from striatal (Fig. 2, Table I), cortical (Fig. 2) or hippocam-
pal (Fig. 2) slices, at rest or during stimulation and with or without exogenous
choline.
Our earlier publication (Savci and Wurtman, 1995) described evidence that
the presence of cytidine (200 µM) could decrease striatal acetylcholine content by
about 18%; in contrast, in the present study, we found no effect of cytidine or uri-
dine (both 25–400 µM) on striatal acetylcholine levels or release, whether or not
choline had been added to the incubation medium (Table II). The apparent dif-
ference between the two sets of findings probably reflects methodological differ-
ences between them: In our earlier study (Savci and Wurtman, 1995), the striatal
slices had been incubated in a static medium for an hour prior to measurement of
acetylcholine, while in the present study the slices were continuously perfused at
the rate of 0.6 mL/min. It is known that acetylcholine accumulates in striatal slices
and its levels increase over physiological concentrations, during periods of static
incubation (Weiler et al., 1979). Indeed the reported value for tissue acetylcholine
content in the previous study, 3037 ± 214 pmol/mg protein, was in good aggrement
with values reported by Weiler et al. (1979) under static incubation condition but
much higher than the values observed in the present study (Table I) or previous
reports (Maire and Wurtman, 1985; Ulus et al., 1989, 1992) from our laboratory
in the perfused striatal slices. We now find that in a perfused slice system, which
is more physiological than a static incubation and less likely to be associated with
accumulation of metabolic products in the medium, added pyrimidines do elevate
phospholipid synthesis without concurrently lowering tissue acetylcholine contents
(Table II).
The transport of choline from the extracellular space to cholinergic neuronal
terminals through the high-affinity choline uptake transporter is essential for main-
taining normal acetylcholine synthesis and, therefore, normal cholinergic transmis-
sion (Ferguson and Blakely, 2004). In the present study, we observed that neither
cytidine nor uridine, at 25–800 µM concentrations, affected [3H]-choline uptake into
striatal synaptosomes. These observations are consistent with the failures of cyti-
dine or uridine to reduce the synthesis or release of acetylcholine from striatal slices
(Fig. 3).
In conclusion, we demonstrate that cytidine or uridine supplementation,
which increases CDP-choline levels and membrane phospholipid synthesis does
not reduce acetylcholine synthesis in or release from brain slices in the presence
or absence of exogenously added choline (20–40 µM). These data suggest that
Ulus, Watkins, Cansev, and Wurtman
giving supplemental cytidine or uridine with choline might increase the membrane
reservoir of bound choline without compromising acetylcholine levels.
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